Abstract:Hematopoiesis is a tightly regulated process that produces all adult blood cells and immune cells from multipotent hematopoietic stem cells (HSCs). HSCs usually remain quiescent, and in the presence of external stimuli like infection or inflammation, they undergo division and differentiation as a compensatory mechanism. Normal hematopoiesis is impacted by systemic inflammation, which causes HSCs to transition from quiescence to emergency myelopoiesis. At the molecular level, inflammatory cytokine signaling molecules such as tumor necrosis factor (TNF), interferons, interleukins, and toll-like receptors can all cause HSCs to multiply directly. These cytokines actively encourage HSC activation, proliferation, and differentiation during inflammation, which results in the generation and activation of immune cells required to combat acute injury. The bone marrow niche provides numerous soluble and stromal cell signals, which are essential for maintaining normal homeostasis and output of the bone marrow cells. Inflammatory signals also impact this bone marrow microenvironment called the HSC niche to regulate the inflammatory-induced hematopoiesis. Continuous pro-inflammatory cytokine and chemokine activation can have detrimental effects on the hematopoietic system, which can lead to cancer development, HSC depletion, and bone marrow failure. Reactive oxygen species (ROS), which damage DNA and ultimately lead to the transformation of HSCs into cancerous cells, are produced due to chronic inflammation. The biological elements of the HSC niche produce pro-inflammatory cytokines that cause clonal growth and the development of leukemic stem cells (LSCs) in hematological malignancies. The processes underlying how inflammation affects hematological malignancies are still not fully understood. In this review, we emphasize the effects of inflammation on normal hematopoiesis, the part it plays in the development and progression of hematological malignancies, and potential therapeutic applications for targeting these pathways for therapy in hematological malignancies.

Nucleic acid-induced inflammation on hematopoietic stem cells

Towards an integrated understanding of inflammatory pathway influence on hematopoietic stem and progenitor cell differentiation

Inflammatory Signaling Regulates Embryonic Hematopoietic Stem and Progenitor Cell Production.

Mobilization of hematopoietic stem cells as a result of innate immunity-mediated sterile inflammation in the bone marrow microenvironment—the involvement of extracellular nucleotides and purinergic signaling

The role of inflammation in hematopoiesis and bone marrow failure: What can we learn from mouse models?

Inflammation as a driver of hematological malignancies

Immuno-Modulation of Hematopoietic Stem and Progenitor Cells in Inflammation

Inflammation, Aging and Hematopoiesis: A Complex Relationship

Inflammation as a regulator of hematopoietic stem cell function in disease, aging, and clonal selection

Inflamm-Aging of Hematopoiesis, Hematopoietic Stem Cells, and the Bone Marrow Microenvironment

Nucleic acid sensing in the central nervous system: Implications for neural circuit development, function, and degeneration

Inflammation perturbs hematopoiesis by remodeling specific compartments of the bone marrow niche

Neuro-immune crosstalk in hematopoiesis, inflammation, and repair

Inflammatory signaling regulates the number of lymphoid progenitors and HSCs in the embryo

Innate immune responses to RNA: sensing and signaling

IL-1β expression in bone marrow dendritic cells is induced by TLR2 agonists and regulates HSC function

The Molecular and Genetic Mechanisms of Inherited Bone Marrow Failure Syndromes: The Role of Inflammatory Cytokines in Their Pathogenesis

The RNA editor ADAR2 promotes immune cell trafficking by enhancing endothelial responses to interleukin-6 during sterile inflammation

Interferon-sensitized hematopoietic progenitors dynamically alter organismal immunity

Viral Infection Sentinel Rig-I Maintains Hematopoietic Stem Cell Function Through Regulating Dna-Damage Response

Innate immune pathways and inflammation in hematopoietic aging, clonal hematopoiesis, and MDS